|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2001-1-2
|
|
pubmed:abstractText |
Depression and hostility are significant risk factors for mortality and morbidity after myocardial infarction (MI). Much research is still needed to identify effective ways to reduce emotional distress in patients with cardiovascular disease. This double-blind, placebo-controlled study investigated the efficacy and safety of the antidepressant fluoxetine in patients with depression after their first MI.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0033-3174
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
62
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
783-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11138997-Adult,
pubmed-meshheading:11138997-Aged,
pubmed-meshheading:11138997-Blood Pressure,
pubmed-meshheading:11138997-Depressive Disorder, Major,
pubmed-meshheading:11138997-Double-Blind Method,
pubmed-meshheading:11138997-Electrocardiography,
pubmed-meshheading:11138997-Female,
pubmed-meshheading:11138997-Fluoxetine,
pubmed-meshheading:11138997-Heart Rate,
pubmed-meshheading:11138997-Hostility,
pubmed-meshheading:11138997-Humans,
pubmed-meshheading:11138997-Life Change Events,
pubmed-meshheading:11138997-Male,
pubmed-meshheading:11138997-Middle Aged,
pubmed-meshheading:11138997-Myocardial Infarction,
pubmed-meshheading:11138997-Risk Factors,
pubmed-meshheading:11138997-Sick Role,
pubmed-meshheading:11138997-Treatment Outcome
|
|
pubmed:articleTitle |
Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial.
|
|
pubmed:affiliation |
Department of Psychiatry, University Hospital Maastricht, The Netherlands. Jacqueline.Strik@spsy.azm.nl
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
